Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Neupulse Wearable Offers Non-Invasive Relief for Tourette's
Tech & Innovation Neupulse Wearable Offers Non-Invasive Relief for Tourette's

For individuals living with the persistent and often debilitating challenges of Tourette’s syndrome, the search for effective management has historically been a choice between invasive surgery and heavy medication. Tourette’s syndrome is a neurological condition characterized by involuntary

Can Retirees Save China From Its Demographic Crisis?
Management & Administration Can Retirees Save China From Its Demographic Crisis?

As the morning mist clears over Beijing’s parks, the sight of elderly citizens practicing tai chi is being replaced by a much more industrious reality as millions of retirees are now re-entering the workforce to combat a shrinking labor pool. This demographic shift represents a pivotal moment in

How Will New FDA Guidance Reshape Payor Communications?
Management & Administration How Will New FDA Guidance Reshape Payor Communications?

Pharmaceutical manufacturers and healthcare payors have historically operated within a rigid framework of regulatory constraints that often delayed the integration of life-saving therapies into patient formularies due to information gaps. This disconnect created significant financial and clinical

Why Is Mental Health Care Still a Luxury in America?
Management & Administration Why Is Mental Health Care Still a Luxury in America?

Across the current landscape of the American medical system, the accessibility of comprehensive mental health care has increasingly become a luxury reserved for those with significant financial means rather than a standard component of basic healthcare. While the societal conversation around

Security Concerns Drive Surge in Medical Device Rejections
Tech & Innovation Security Concerns Drive Surge in Medical Device Rejections

The rapid evolution of interconnected healthcare systems has forced a fundamental shift in how regulatory bodies evaluate the safety and efficacy of diagnostic and therapeutic equipment. Since the mandate granting authorities the power to reject submissions based solely on cybersecurity grounds

Can AI Digital Twins Predict the Progression of ALS?
Tech & Innovation Can AI Digital Twins Predict the Progression of ALS?

The sheer unpredictability of amyotrophic lateral sclerosis often proves as devastating to families as the physical symptoms themselves, leaving patients and clinicians in a state of perpetual reactive waiting. At Temple University and Temple Health in Philadelphia, a pioneering research initiative

How Can Independent Pharmacies Master Medical Billing?
Management & Administration How Can Independent Pharmacies Master Medical Billing?

The traditional landscape of independent pharmacy operations has undergone a radical transformation as professional service fees and clinical interventions begin to eclipse the shrinking margins once provided by standard prescription fulfillment. This seismic shift requires pharmacists to navigate

How Is Supply Chain Volatility Impacting Care Innovation?
Tech & Innovation How Is Supply Chain Volatility Impacting Care Innovation?

The era of predictable procurement has vanished, replaced by a volatile landscape where a single shortage of semiconductor components can derail multi-million-dollar clinical expansion projects overnight. Healthcare systems that once relied on just-in-time delivery for everything from surgical

Can Crinetics End the Era of Endocrine Injections?
Management & Administration Can Crinetics End the Era of Endocrine Injections?

The landscape of endocrine medicine is undergoing a profound transformation as the traditional reliance on invasive, monthly injections for rare hormonal disorders is finally being challenged by highly effective oral alternatives. For decades, patients suffering from conditions such as acromegaly

New Research Highlights Cannabinoid Anti-Tumor Potential
Clinical & Pharma New Research Highlights Cannabinoid Anti-Tumor Potential

The long-standing skepticism surrounding the clinical utility of cannabis-derived compounds is rapidly giving way to a new era of rigorous, data-driven oncological investigation. A comprehensive systematic review recently conducted by researchers from Semmelweis University and the University of

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later